Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam versus propofol induction and cardiac systolic/diastolic function in elderly patients
ChiCTR2500099283Phase 4Completed
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam and propofol (2 arms), sponsored by Southern Medical University Zhujiang Hospital. Primary endpoints: Ejection fraction and Ratio of early to late diastolic mitral flow velocity. Started Mar 2025; status: completed.
02
Drugs
remimazolampropofol
Beyond the preview
Go deeper on ChiCTR2500099283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500099283.